Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform
|Articles|April 27, 2023

Organ on a Chip Data Integrity Discussion with Issac Bentwich (INTERPHEX 2023)

Isaac Bentwich, MD, CEO and co-founder of Quris-AI, discusses organ on a chip technology.

Isaac Bentwich, MD, CEO and co-founder of Quris-AI, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, gives his thoughts on the confidence level of data generated from organ on a chip technology.

For more INTERPHEX 2023 video content, check this page for updates.


Related to this article

The BioPharm Brief: Cosentyx Approved in Polymyalgia Rheumatica, a Phase 3 Survival Win for an AML Vaccine, and $173 Million for In Vivo Bone Marrow Editing
FDA approves Novartis’ Cosentyx as the first anti-IL-17 biologic for polymyalgia rheumatica, SELLAS Life Sciences’ WT1-targeted peptide vaccine galinpepimut-S meets its overall survival primary endpoint in the phase 3 REGAL trial in AML, and Marrow Therapeutics launches with $173 million to develop bone marrow-targeted genetic medicines.